Procter & Gamble Company (The) $PG is Addison Capital Co’s 5th Largest Position

Addison Capital Co decreased its position in Procter & Gamble Company (The) (NYSE:PG) by 4.6% during the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 51,295 shares of the company’s stock after selling 2,461 shares during the period. Procter & Gamble comprises approximately 3.4% of Addison Capital Co’s portfolio, making the stock its 5th biggest holding. Addison Capital Co’s holdings in Procter & Gamble were worth $8,742,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in PG. Capital A Wealth Management LLC bought a new position in shares of Procter & Gamble during the fourth quarter valued at about $31,000. Quarry LP purchased a new position in Procter & Gamble during the 1st quarter valued at about $33,000. 10Elms LLP bought a new position in Procter & Gamble during the 4th quarter valued at approximately $34,000. Sunbeam Capital Management LLC purchased a new stake in Procter & Gamble in the 4th quarter worth approximately $34,000. Finally, Mizuho Securities Co. Ltd. grew its position in shares of Procter & Gamble by 566.7% in the 1st quarter. Mizuho Securities Co. Ltd. now owns 200 shares of the company’s stock worth $34,000 after buying an additional 170 shares during the last quarter. 65.77% of the stock is currently owned by institutional investors.

Procter & Gamble Stock Down 1.2%

Shares of Procter & Gamble stock opened at $157.49 on Thursday. Procter & Gamble Company has a 1 year low of $149.91 and a 1 year high of $180.43. The firm has a market cap of $368.59 billion, a price-to-earnings ratio of 24.19, a PEG ratio of 4.21 and a beta of 0.36. The company has a 50-day moving average of $156.30 and a 200 day moving average of $162.09. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.70 and a quick ratio of 0.49.

Procter & Gamble (NYSE:PG) last announced its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, topping analysts’ consensus estimates of $1.42 by $0.06. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The business had revenue of $20.89 billion for the quarter, compared to analysts’ expectations of $20.79 billion. During the same quarter in the prior year, the company earned $1.40 earnings per share. The business’s revenue was up 1.7% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, sell-side analysts anticipate that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.

Procter & Gamble Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Friday, July 18th were given a dividend of $1.0568 per share. This represents a $4.23 dividend on an annualized basis and a yield of 2.7%. The ex-dividend date of this dividend was Friday, July 18th. Procter & Gamble’s dividend payout ratio (DPR) is 64.98%.

Wall Street Analyst Weigh In

PG has been the subject of a number of research analyst reports. UBS Group set a $180.00 price target on Procter & Gamble and gave the stock a “buy” rating in a research note on Wednesday, July 30th. Barclays set a $164.00 price objective on shares of Procter & Gamble and gave the stock an “equal weight” rating in a report on Thursday, July 31st. JPMorgan Chase & Co. reaffirmed a “neutral” rating and set a $170.00 target price (down previously from $178.00) on shares of Procter & Gamble in a research note on Friday, July 25th. Evercore ISI reissued an “in-line” rating and issued a $170.00 price target (down from $190.00) on shares of Procter & Gamble in a research note on Monday, July 14th. Finally, Wells Fargo & Company lowered their price objective on shares of Procter & Gamble from $175.00 to $173.00 and set an “overweight” rating for the company in a report on Wednesday, July 30th. One equities research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and seven have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Procter & Gamble currently has a consensus rating of “Moderate Buy” and an average target price of $175.12.

Insider Buying and Selling at Procter & Gamble

In other news, CFO Andre Schulten sold 11,638 shares of the firm’s stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total transaction of $1,830,308.26. Following the completion of the transaction, the chief financial officer directly owned 52,642 shares in the company, valued at $8,279,007.34. This trade represents a 18.11% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Gary A. Coombe sold 10,194 shares of the company’s stock in a transaction dated Thursday, August 21st. The stock was sold at an average price of $158.16, for a total transaction of $1,612,283.04. Following the completion of the transaction, the chief executive officer owned 34,978 shares in the company, valued at approximately $5,532,120.48. The trade was a 22.57% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 120,181 shares of company stock valued at $18,918,012 in the last ninety days. Corporate insiders own 0.20% of the company’s stock.

About Procter & Gamble

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.